We take a patient-focused approach to tackling the spectrum of venous diseases. We understand that patients with deep venous disease can present with unique challenges and at any stage of the venous disease progression cycle. Cook Medical’s solutions have been designed to stop progression and/or minimize the impact of deep venous disease.
Cook recognizes the complexity of venous disease and that it will require more than just products to improve outcomes for patients. We are committed to driving development of venous therapies for the benefit of the patient, and will achieve this through multiple efforts:
Pulmonary embolism (PE) is a life-threatening condition that can be prevented. While anticoagulation therapy is the gold standard of prevention, a subset of patients at risk are contraindicated for anticoagulation, even if for a short period of time. In those instances, inferior vena cava (IVC) filters are the only option available to protect against PE.
Once protection from PE is no longer necessary, filter retrieval should be considered. Filter retrieval should be attempted when feasible and clinically indicated. Filter retrieval is a patient-specific, clinically complex decision; the decision to remove a filter should be based on each patient’s individual risk/benefit profile.
Iliofemoral venous outflow obstruction may be due to inadequate recanalization of a previous deep vein thrombosis (DVT) or external compression resulting in symptomatic venous hypertension. Recanalization is necessary in cases where iliofemoral venous outflow obstruction needs to be treated. Cook Medical offers a solution to recanalize the vessel by crossing the lesions with the TriForce peripheral crossing set, offering the opportunity to stent the lesion with the Zilver Vena Venous Self-Expanding Stent.
1. Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am J Prev Med. 2010;38(4 Suppl):S495-S501.
2. Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2005;111:2398-2409.